Issue 6/2021
Content (9 Articles)
The NOP Receptor System in Neurological and Psychiatric Disorders: Discrepancies, Peculiarities and Clinical Progress in Developing Targeted Therapies
Lawrence Toll, Andrea Cippitelli, Akihiko Ozawa
Pharmacology of Cenobamate: Mechanism of Action, Pharmacokinetics, Drug–Drug Interactions and Tolerability
Roberta Roberti, Carmen De Caro, Luigi Francesco Iannone, Gaetano Zaccara, Simona Lattanzi, Emilio Russo
Irritability in Mood Disorders: Neurobiological Underpinnings and Implications for Pharmacological Intervention
Erica Bell, Phil Boyce, Richard J. Porter, Richard A. Bryant, Gin S. Malhi
Viloxazine in the Management of CNS Disorders: A Historical Overview and Current Status
Robert L. Findling, Shawn A. Candler, Azmi F. Nasser, Stefan Schwabe, Chungping Yu, Jennie Garcia-Olivares, Welton O’Neal, Jeffrey H. Newcorn
Comparing Long-Acting Antipsychotic Discontinuation Rates Under Ordinary Clinical Circumstances: A Survival Analysis from an Observational, Pragmatic Study
Federico Bertolini, Giovanni Ostuzzi, Michela Pievani, Andrea Aguglia, Francesco Bartoli, Paola Bortolaso, Camilla Callegari, Mariarita Caroleo, Giuseppe Carrà, Mariangela Corbo, Armando D’Agostino, Pasquale De Fazio, Fabio Magliocco, Giovanni Martinotti, Edoardo Giuseppe Ostinelli, Marco Piero Piccinelli, Federico Tedeschi, Corrado Barbui
Effect of a Multi-Layer, Extended-Release Methylphenidate Formulation (PRC-063) on Sleep in Adults with ADHD: A Randomized, Double-Blind, Forced-Dose, Placebo-Controlled Trial Followed by a 6-month Open-Label Extension
Margaret Danielle Weiss, Craig Surman, Atul Khullar, Ellie He, Marc Cataldo, Graeme Donnelly
Erythropoietin Improves Poor Outcomes in Preterm Infants with Intraventricular Hemorrhage
Juan Song, Yong Wang, Falin Xu, Huiqing Sun, Xiaoli Zhang, Lei Xia, Shan Zhang, Kenan Li, Xirui Peng, Bingbing Li, Yaodong Zhang, Wenqing Kang, Xiaoyang Wang, Changlian Zhu
Diroximel Fumarate in Relapsing Forms of Multiple Sclerosis: A Profile of Its Use
Julia Paik
Correction to: OnabotulinumtoxinA in Chronic Migraine: A Profile of Its Use
James E. Frampton